Rajasthan reports fresh Covid cases in Jaipur from Bharatpur and Jhunjhunu. NITI Aayog's Dr VK Paul assures citizens that the new JN.1 variant does not cause..

Dr Paul assured that there is no need to panic, emphasising that while the virus has the potential to spread, the disease's impact remains relatively mild.

Dr VK Paul, a member of NITI Aayog, has called for increased support from the private sector to deliver quality healthcare in India. He emphasized the..

Talking about the slow rate of vaccination, Dr VK Paul said that there is no dearth of vaccine availability and hence the eligible persons should get themselves..

"The team will be headed by Dr VK Paul, member (Health), NITI Aayog and members including Secretary, Union Health Ministry, Pharma and Biotech," sources said. 

"We can see that the surge has settled, but we must also know that there are cases at a significant number. Hopefully, it will be sustained but we cannot lower..

NITI Aayog's Dr VK Paul talked about whether all the adults in India will need to get the third shot of the Covid-19 vaccine to battle the pandemic.

Dr VK Paul, Member-Health, Niti Aayog, said, "Overall COVID-19 situation is very optimistic. However, some states including Kerala, Mizoram, Himachal Pradesh are..

"Omicron is not a common cold, it is society`s responsibility to slow it down with vaccination and masks," NITI Aayog’s Member, Health, Dr VK Paul said. 

The ‘precaution dose’ (booster) for Covid-19 — which will be administered from January 10 to health and frontline workers, and those above 60 with..

"Those who've received Covaxin will receive Covaxin, those who've received primary two doses of Covishield will receive Covishield," said Dr VK Paul,..

"We have to remember that both vaccines and masks are important," Dr VK Paul emphasised.

Prime Minister Narendra Modi on Saturday chaired a meeting with top officials amid rising concerns over new Covid-19 strain Omicron in India.Top officials..

Dr VK Paul, Member (Health), Niti Aayog said the ZyCoV-D vaccine administration requires special training.

India's indigenously-developed Covid vaccine Covaxin may soon receive Emergency Use Listing by the World Health Organisation, eventually enabling its recipients..

As India crossed the landmark of administering over 75 crore Covid-19 vaccine doses on Tuesday, Niti Aayog Member (Health) Dr VK Paul said that vaccine is a..

Dr VK Paul said that the battle against COVID-19 will require a studied combination of vaccines, effective drugs, and disciplined social behaviour.

Union health ministry in its weekly press conference on Friday cautioned that the next 100 to 125 days are critical in the fight against Covid-19 in India. "Fall..

NITI Aayog Member (Health) Dr VK Paul during a media briefing said that globally, the third wave of COVID-19 is being seen and appealed the public to make..

NITI Aayog Member (Health) Dr VK Paul said that Kappa strain was also found in India in the months of February and March, however, it was suppressed after Delta..

Appreciating the Janssen vaccine, Dr VK Paul said, "It is a good single-dose vaccine. Single doses can be used to complete the full course."

 NITI Aayog member (Health) Dr VK Paul said, "We are in talks with Johnson & Johnson regarding their single-dose vaccine." 

VK Paul, who is also a Niti Aayog Member, asserted that there is no scientific data so far to establish that the new variant is highly transmissible or reduces..

During a Union Health Ministry's media briefing on COVID-19, Dr VK Paul, Member (Health), NITI Aayog, explained the reasons behind the emergence of new pandemic..

Dr Paul said that the third wave of the pandemic can be stopped if COVID-appropriate behaviour is followed and majority of the people get vaccinated.

India's COVID-19 vaccination coverage is nearing 29 crore after 86.16 lakh vaccine doses were administered across the country on Monday. 

“A lot of things need to be considered while deciding on the reopening schools. This is a question that keeps coming up,” said NITI Aayog (health) member..

(health) member Dr VK Paul said that the government will consider reopening schools only when the majority of teachers and staff are vaccinated.

Studies show that vaccinations can help reduce post-Covid hospitalisation by almost 75-80 per cent and bring down oxygen requirement to just 8%, the government..

Dr VK Paul, member (Health) at NITI Aayog, said that these decisions must be taken very carefully.

Dr Vinod K Paul, Member (Health) in NiTi Aayog, said that the Centre is allotting enough vaccines to the states in a transparent manner as per agreed..

Covaxin received the DCGI nod to conduct clinical trials in children on May 11. 

The Niti Aayog member (Health) Dr VK Paul on Thursday (May 13, 2021) outlined the central government’s plan which involved a total of eight COVID-19 vaccines..

Russia’s Sputnik V vaccine for COVID-19 has arrived in India and is likely to hit markets from next week, informed NITI Aayog member Dr VK Paul on Thursday..

Amid the reports of coronavirus vaccine shortage from various states, the Central government and Hyderabad-based Bharat Biotech are willing to invite other..

Dr VK Paul, member (health) of the NITI Aayog said the production of Sputnik is scheduled to begin in India by July.

Regarding other vaccine candidates such as Pfizer, Moderna, Johnson & Johnson, Dr Paul said that the authorities are constantly in touch with the manufacturers.

NITI Aayog member Dr VK Paul said that the Centre has already given guidelines to the state governments on sanctions to break the chain of infection.

Niti Aayog member (Health) Dr VK Paul on Monday said the time has come to wear masks even at home, especially if there is an infected person around.

Dr VK Paul further said that people should also avoid stepping out of their homes unnecessarily and not invite guests at home.

 Dr VK Paul said, "Questions are being asked whether the vaccine can be taken by women during menstruation. The answer is yes, the vaccine can be taken during..